The Quantiplasma Array from Randox is a monoclonal antibody microarray designed to assess the level of multiple proteins simultaneously in human plasma.
Each kit contains 300 unique monoclonal antibodies, so by using the Quantiplasma Array it is possible to directly assess the plasma proteome dynamics of normal and disease state plasma samples for identification of novel biomarkers in conjunction with Randox's Biochip Array Technology analyser platform.
Randox has been supplying the CRO's, pharmaceutical and biotech companies from all over the world for nearly three decades, and claims to have unrivalled in-house technical know-how, whether in the development of new biomarker assays, companion diagnostics or the manufacture of the highest quality clinical diagnostic reagents.
Randox already supplies more than 400 biomarker assays from its current product portfolio, and products such as the Quantiplasma Array demonstrates how it is investing in developing solutions for biomarker discovery.
